Summer 2026

Intern Product Manager

Interbody

Posted on 2/21/2026

Orthofix

Orthofix

1,001-5,000 employees

Develops spine and orthopedic reconstructive devices

Compensation Overview

$22 - $26/hr

Carlsbad, CA, USA

In Person

Category
Product (1)
Requirements
  • Pursuing a Bachelor’s degree in Biomedical Engineering, Mechanical Engineering, Business, Marketing, or a related field; High School Diploma or equivalent and pursuing college degree.
Responsibilities
  • Market & Competitive Analysis: Research market trends, competitor product offerings, and clinical applications within thoracolumbar spinal interbody space; Create reports and presentations to summarize key findings.
  • Product Development & Support: Assist in the evaluation of new and existing implants and instruments for thoracolumbar interbody; Participate in cadaveric labs and surgeon feedback sessions to gather insights; Support the product manager in data collection, testing, and documentation.
  • Sales & Business Support: Analyze sales performance, pricing trends, and customer feedback for anterolateral interbody products; Assist with sales training materials, product guides, and marketing collateral; Help prepare internal and external presentations for product updates.
  • Operational & Cross-Functional Collaboration: Work with R&D, marketing, regulatory, and supply chain teams to track product milestones; Support planning for product launches, line extensions, and instrument enhancements; Contribute to the creation of FAQs, case studies, and training modules for field sales teams.
Desired Qualifications
  • Proficiency in Microsoft Office (Excel, PowerPoint, Word); experience with Power BI
  • Interest in medical devices, orthopedics, or spine surgery
  • Strong analytical and problem-solving skills
  • Excellent verbal and written communication skills
  • Ability to work independently and manage multiple tasks in a fast-paced environment
  • Exposure to surgeon engagement, clinical insights, and market strategy

Orthofix Medical Inc. focuses on reconstructive and regenerative orthopedic and spine solutions for surgeons and hospitals. It operates in two groups: Global Spine, which offers spinal fusion products such as bone growth stimulators, spinal implants, and biologics, and Global Orthopedics, which provides devices for fracture fixation, deformity correction, and bone reconstruction. The company’s products are used to treat musculoskeletal conditions like degenerative disc disease, spinal stenosis, and fractures, and are sold through a direct sales force and a network of independent distributors in the U.S. and internationally. Orthofix grows by developing and commercializing new products and by acquiring complementary technologies and businesses, expanding its portfolio and market reach. Its goal is to improve musculoskeletal health by delivering a broad range of surgical solutions for spine and orthopedic care.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Lewisville, Texas

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Top 30 distributors delivered 27% growth in Q1 2026.
  • VIRATA launches should drive second-half 2026 Spine Fixation acceleration.
  • Management expects Limb Reconstruction to return to double-digit U.S. growth.

What critics are saying

  • New product launches lack robust clinical validation and surgeon adoption.
  • Distributor dependence creates immediate exposure to partner defection and pricing pressure.
  • 2026 guidance leaves little cushion if Spine Fixation or Therapeutic Solutions disappoint.

What makes Orthofix unique

  • Orthofix spans spine, limb reconstruction, biologics, and 7D FLASH navigation.
  • FITBONE Trochanteric targets pediatric and small-stature patients with trochanteric femoral entry.
  • OrthoNext 2.1 integrates planning software with fixation workflows and 3D modeling.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Orthofix who can refer or advise you

Benefits

Performance Bonus

Company News

Yahoo Finance
Apr 9th, 2026
Orthofix restructures spine leadership, reports $196.7M Q1 sales and reaffirms 2026 outlook

Orthofix Medical has restructured its Spine leadership team to accelerate growth and execution, with key leaders now reporting directly to CEO Massimo Calafiore. The company eliminated the President, Global Spine Solutions role, whilst Shaeffer Bannigan assumes expanded responsibilities for Spine strategy and commercial operations. The medical technology company reported preliminary first quarter 2026 net sales of approximately $196.7 million, representing a 0.4% increase on a reported basis and 3% growth on a non-GAAP pro forma constant currency basis compared to Q1 2025. Non-GAAP pro forma net sales, excluding M6 disc sales, totalled approximately $196.4 million. The reorganisation aims to streamline decision-making and strengthen focus on the 7D navigation platform commercialisation. Patrick Fisher has also expanded his remit to include Biologics alongside Limb Reconstruction.

Precedence Research
May 30th, 2025
Xtant Medical Launches OsteoFactor Pro A Groundbreaking Growth Factor Solution to Advance Bone Healing

Xtant Medical launches OsteoFactor Pro A groundbreaking growth factor solution to advance bone healing.

Stock Titan
Mar 12th, 2025
Orthofix Announces Appointment of Vickie Capps to Board of Directors

Orthofix announces Appointment of Vickie Capps to Board of Directors.

PR Newswire
Feb 27th, 2025
The World Brain Mapping Foundation Rises From The Ashes Of The Pacific Palisades Fires To Host The Prestigious Gala And Convention In Los Angeles On The Eve Of The Oscars

LOS ANGELES, Feb. 26, 2025 /PRNewswire/ -- The World Brain Mapping Foundation (WBMF) is set to make a powerful comeback. On March 1st, it will host its 22nd Annual Gathering for the Cure (GFC) award gala at the Millennium Biltmore Hotel in Los Angeles. The red carpet will take place from 6:00 to 8:00 p.m., followed by the award banquet from 8:00 to 11:00 p.m

BioSpace
Feb 18th, 2025
Orthofix To Participate In The Canaccord Genuity 2025 Musculoskeletal Conference

Monday, March 10, 2025 at 9:00 am Pacific TimeLEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 9:00 am PT.Interested parties can access the live and archived webcast of the presentation in the “Events & Presentations” section of the Orthofix investor relations website at ir.orthofix.com.Internet Posting of InformationOrthofix routinely posts information that may be important to investors in the “Investors” section of its website at www.orthofix.com. The Company encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix.About OrthofixOrthofix is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, we deliver exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH™ navigation system

INACTIVE